If your child is 12 to 17 years old and has been diagnosed with major depressive disorder (MDD), or has been having feelings of depression for at least the past 6 weeks, he or she may be eligible to join the STEADi (Study to Evaluate an Adolescent Depression Investigational drug) clinical research study.This study is being done to find out if an investigational drug is safe and if it works for adolescents with MDD. The drug is currently FDA-approved in the US for use only in adults. The study will last for about 10 weeks and there will be about 9 study visits.To learn more:410-602-1440www.pharmasiteresearch.comPharmaSite Research, Inc.Robert B. Lehman, MD - Principal InvestigatorAlan M. Jonas, MD - Sub-Investigator

By clicking 'Continue', I consent to be contacted regarding education opportunities at the phone number provided: , using an automated telephone dialing system and/or pre-recorded voice. I may be contacted by Career Advisor. Consent is not required as a condition of using this service.